Indonesia ranked 6th from countries with the highest burden of drug-resistant pulmonary tuberculosis (PTB). A rate of 1.9% of new cases develop to be resistant and even 12% from previous treated cases. Previous studies concluded determinants of drug-resistant PTB, however, the study in Indonesia, especially in the scope of hospitals is still limited. Our study aims to explore the determinant of drug-resistant PTB in Dr. Kariadi General Hospital. We conducted a case-control study, using data from medical records. A sample of 76 cases and 76 controls have met the criterion and were involved in the study. The status of drug-resistant cases determined by rapid molecular test. We observed the subject's characteristics and determinants of drug-resistant PTB. Study shows that there is no significant difference in the subject's characteristics, i.e. age, sex, level of education, and working status between the group of cases and controls. Chi-square analysis shows that history of previous treatment, HIV infection, drug side-effects status, Acid-Fast Bacilli (AFB) gradation, and duration of treatment were related to drug-resistant pulmonary TB. After conducted Binary Logistic Regression, we concluded that history of treatment (OR=24.3; 95%CI: 8.49-69.33) and AFB gradation (OR=13.8; 95% CI: 2.76-68.60) altogether as dominant determinants of drug-resistant PTB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.